相关实验视频
Updated: Jul 4, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
基于外体的输送策略用于瘤治疗:修改,加载和临床应用的最新情况
Qian Yang1, Shisheng Li2, Haibo Ou1
1Department of Otorhinolaryngology Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
外体显示出希望作为癌症治疗的药物输送载体,克服当前治疗的局限性. 本综述探讨了它们在安全有效的抗瘤药物输送方面的潜力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 恶性瘤是全球主要的死亡原因,目前的治疗方法面临着溶解性差和毒性等挑战.
- 外体,自然细胞衍生的纳米粒子,由于其生物相容性和准能力,提供了潜在的解决方案.
- 开发有效的药物输送系统对于改善抗癌治疗结果至关重要.
研究的目的:
- 审查利用外体细胞作为瘤治疗药物载体的最新进展.
- 讨论对外体的隔离,鉴定,药物加载和修改,以提高治疗效果.
- 为瘤学中的基于外体的药物递送系统提供科学基础.
主要方法:
- 文献综述总结了对外体生物发生,表征和药物递送中的应用的当前研究.
- 对外体隔离和鉴定技术的分析.
- 讨论用于向药物输送和治疗疗效的外体细胞修饰策略.
主要成果:
- 外体具有诸如纳米尺寸,生物相容性和自然向等固有的特性,使其成为理想的药物载体.
- 最近的进展使得有效的隔离,识别,药物加载和对外体的修饰成为可能.
- 基于外体的药物递送系统在临床前瘤模型中显示出提高安全性和疗效的潜力.
结论:
- 外体体是开发癌症治疗中新型向药物递送系统的有希望的平台.
- 进一步研究克服挑战和优化外体工程对于临床翻译至关重要.
- 本综述强调了外体介导瘤治疗的科学基础和未来方向.
更多相关视频
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
相关概念视频
Tumor Immunotherapy
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...